Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does The Positive Reno-Protective Effect Of Sodium Glucose Co-Transporter 2 Inhibitors Extend To Lupus Nephritis Population?

NCT07700940 is registered in ClinicalTrials.gov with Ahmed Yehia Ismail as lead sponsor.

NCT NCT07700940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07700940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does The Positive Reno-Protective Effect Of Sodium Glucose Co-Transporter 2 Inhibitors Extend To Lupus Nephritis Population?
Lead sponsor
Ahmed Yehia Ismail
Phase
Phase 4
Overall status
Recruiting
Start date
January 22, 2024
Completion date
December 30, 2026
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis (ln)